Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- I Am Legend 2 Has A Director In Steven Caple Jr
- The German refugees who found shelter in Yugoslavia
- New Paris exhibition showcases work of US photographer and war reporter Lee Miller
- Park Chan-wook to direct western ‘The Brigands Of Rattlecreek’ starring Matthew McConaughey, Pedro Pascal, Austin Butler | News
- Post-Streetwear Boom, Who Can Win China’s Menswear Market?
- This dress from M&S has the color combination of this spring
- Meer rechtszaken over social washing en greenwashing in de mode-industrie
- Helena Bonham Carter Leaving ‘The White Lotus’ Season 4, Will Be Recast
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
